secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nu-Med Plus, Inc. (NUMD)
CIK:        0001543637
Form:       8-K
Filed at:   2022-09-13T23:59:59+00:00
Accession:  0001548123-22-000147
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CEO Jeffrey Robins resigns; William Hayde appointed as CEO and Chairman
-----------------------------------------------------------------------

- Jeffrey L. Robins resigned as President, CEO, Director and Chairman on Sept 12, 2022; Dr. Brett J. Earl resigned as director.
- William Hayde appointed as President, CEO, Director and Chairman; granted an Employment Agreement.
- Company authorized issuance of 2,000,000 restricted shares to Hayde Family Revocable Trust for past services.
- Keith L. Merrell, CFO, entered new Employment Agreement replacing the prior 2018 agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1543637/000154812322000147/0001548123-22-000147-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1543637/000154812322000147/k91222.htm
  HTML page:      https://secwatch.observer/filing/0001548123-22-000147

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer